Verano Holdings (VRNO) Tax Provisions (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Tax Provisions of $11.6 million for Q1 2026, down 33.0% year-over-year from $17.3 million in Q1 2025, and up 8.26% quarter-over-quarter from $10.7 million in Q4 2025.
Verano Holdings (VRNO) Tax Provisions (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Tax Provisions for 6 consecutive years, with $11.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions fell 33.0% year-over-year to $11.6 million; the TTM figure through Mar 2026 stood at $86.0 million (up 79.76% YoY), while the FY2025 annual figure was $91.7 million, up 118.57% from the prior year.
- Tax Provisions improved to $11.6 million in Q1 2026 per VRNO's latest filing, from $10.7 million in the prior quarter.
- Across five years, Tax Provisions topped out at $69.4 million in Q3 2022 and bottomed at -$45.5 million in Q4 2024.
- Historically, Tax Provisions has averaged $20.6 million across 5 years, with a median of $27.7 million in 2023.
- Annual changes were most pronounced in 2023 — Tax Provisions jumped 8499.62% — and 2024, when it sank 202.69%.
- Verano Holdings' Tax Provisions stood at -$528000.0 in 2022, then surged by 8499.62% to $44.4 million in 2023, then tumbled by 202.69% to -$45.5 million in 2024, then surged by 123.57% to $10.7 million in 2025, then grew by 8.26% to $11.6 million in 2026.
- Business Quant data shows VRNO's Tax Provisions at $11.6 million in Q1 2026, $10.7 million in Q4 2025, and $28.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Verano Holdings | 450.50 Mn | 365.31 Mn | 99.70 Mn | 2.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.93 Mn |
| Mar 31, 2026 | 11.62 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Sep 30, 2025 | 28.44 Mn |
| Jun 30, 2025 | 35.15 Mn |
| Mar 31, 2025 | 17.35 Mn |
| Dec 31, 2024 | -45.54 Mn |
| Sep 30, 2024 | 45.48 Mn |
| Jun 30, 2024 | 30.53 Mn |
| Mar 31, 2024 | 11.48 Mn |
| Dec 31, 2023 | 44.35 Mn |
| Sep 30, 2023 | 44.80 Mn |
| Jun 30, 2023 | 27.68 Mn |
| Mar 31, 2023 | 28.32 Mn |
| Dec 31, 2022 | -528,000.00 |
| Sep 30, 2022 | 69.38 Mn |
| Jun 30, 2022 | 11.10 Mn |
| Mar 31, 2022 | -20.27 Mn |
| Dec 31, 2021 | 37.05 Mn |
| Sep 30, 2021 | 27.09 Mn |